ZA946595B - Mutants of the retinoblastoma and P53 genes and uses thereof - Google Patents

Mutants of the retinoblastoma and P53 genes and uses thereof

Info

Publication number
ZA946595B
ZA946595B ZA946595A ZA946595A ZA946595B ZA 946595 B ZA946595 B ZA 946595B ZA 946595 A ZA946595 A ZA 946595A ZA 946595 A ZA946595 A ZA 946595A ZA 946595 B ZA946595 B ZA 946595B
Authority
ZA
South Africa
Prior art keywords
retinoblastoma
mutants
genes
Prior art date
Application number
ZA946595A
Other languages
English (en)
Inventor
Yuen Kai Fung
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of ZA946595B publication Critical patent/ZA946595B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA946595A 1993-09-03 1994-08-30 Mutants of the retinoblastoma and P53 genes and uses thereof ZA946595B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11694393A 1993-09-03 1993-09-03

Publications (1)

Publication Number Publication Date
ZA946595B true ZA946595B (en) 1996-02-28

Family

ID=22370189

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946595A ZA946595B (en) 1993-09-03 1994-08-30 Mutants of the retinoblastoma and P53 genes and uses thereof

Country Status (11)

Country Link
US (1) US6590086B1 (fr)
EP (1) EP0716660A4 (fr)
JP (1) JP3626189B2 (fr)
KR (1) KR100386899B1 (fr)
CN (1) CN1137262C (fr)
AU (1) AU692793B2 (fr)
CA (1) CA2170605C (fr)
NZ (1) NZ273205A (fr)
RU (1) RU2204601C2 (fr)
WO (1) WO1995006661A1 (fr)
ZA (1) ZA946595B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
GB9521544D0 (en) * 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof
CA2257972A1 (fr) * 1996-06-13 1997-12-18 Consejo Superior De Investigaciones Cientificas Proteines vegetales
JP2001502522A (ja) 1996-06-13 2001-02-27 コンセホ・スペリヨル・デ・インベステイガシヨンズ・シエンテイフイカス 網膜芽細胞腫関連植物蛋白
WO2000022115A2 (fr) * 1998-10-13 2000-04-20 Board Of Regents, The University Of Texas System Dosages permettant d'identifier des alterations fonctionnelles dans le gene suppresseur de tumeur p53

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE168135T1 (de) * 1988-01-21 1998-07-15 Massachusetts Eye & Ear Infirm Diagnose von retinoblastoma
ZA909755B (en) * 1989-12-07 1991-09-25 Res Dev Foundation Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
US5262321A (en) * 1991-05-31 1993-11-16 Dana-Farber Cancer Institute DNA encoding p107 tumor suppressor
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes
WO1995017213A1 (fr) * 1993-12-21 1995-06-29 Sloan-Kettering Institute For Cancer Research Fragments polypeptidiques a base de p53, molecules d'acides nucleiques codant ces derniers et utilisations pertinentes
US6025127A (en) * 1994-01-14 2000-02-15 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection in histologic tissue
US5656282A (en) * 1995-01-05 1997-08-12 The Procter & Gamble Company Package for containing and applying a bug repellent patch

Also Published As

Publication number Publication date
KR100386899B1 (ko) 2004-03-24
CA2170605C (fr) 2004-06-01
AU7642694A (en) 1995-03-22
EP0716660A4 (fr) 1997-09-17
RU2204601C2 (ru) 2003-05-20
EP0716660A1 (fr) 1996-06-19
CA2170605A1 (fr) 1995-03-09
JPH09502183A (ja) 1997-03-04
WO1995006661A1 (fr) 1995-03-09
NZ273205A (en) 2001-04-27
CN1137262C (zh) 2004-02-04
KR960704912A (ko) 1996-10-09
JP3626189B2 (ja) 2005-03-02
AU692793B2 (en) 1998-06-18
CN1133595A (zh) 1996-10-16
US6590086B1 (en) 2003-07-08

Similar Documents

Publication Publication Date Title
IL122392A0 (en) Structurally determined metallo-constructs and applications
PL316875A1 (en) Rps2 gene and applications thereof
IL126057A0 (en) A multi-structure ballistic material and a method of utilizing the same
IL122428A0 (en) Minizymes and minribozymes and uses thereof
ZA945720B (en) Electrode and preparation thereof
AU2651595A (en) Aluminum-scandium alloys and uses thereof
AU6201194A (en) Container and its application
ZA94752B (en) Case forming materials and components and structures thereof
AU7716294A (en) Improved structural strength coating and material
ZA9510821B (en) Mutants of the rb and p53 genes and uses thereof
AU6899994A (en) Novel macrolides and the use thereof
EP0784700A4 (fr) Souches reporteurs mycobacteriennes et leurs utilisations
AU4100593A (en) Iminoalcohol-oxazolidine mixtures and their use
GB2303632B (en) Curable emulsion and coating material comprising the same
ZA946595B (en) Mutants of the retinoblastoma and P53 genes and uses thereof
AU6809594A (en) Colletotrichum and use thereof
GB9408732D0 (en) Pigmentary material
AU6529494A (en) Electrographic element and process
GB9307287D0 (en) Improved tabs and manufacture thereof
PL305644A1 (en) Pigment material, method of obtaining same and application thereof
GB9309992D0 (en) Tribochromic compounds and their applications
AU1292995A (en) Bis-oxazolidine compounds and their use
AU7078094A (en) Allatostatins and their use
AU6481394A (en) Wall stud and nogging
CA75228S (en) Briefcase and interior